Multiomics combined with machine learning defines unique molecular subtypes of cholangiocarcinoma and identifies TNK1 as a therapeutic target.

Journal:

Hepatology

Published:

2025-09-30

DOI:

10.1097/hep.0000000000001535

Affiliations:

13

Authors:

27

Go to article

Institutions	Authors	Share
Mayo Clinic, United States of America (USA)	22.666667 22.666667 22.666667	0.84
Huntsman Cancer Institute at the University of Utah (HCI), Utah, United States of America (USA)	2.500000	0.09
The University of Utah (Utah), United States of America (USA)	1.000000	0.04
Health Sciences Center (HSC), Utah, United States of America (USA)	0.500000	0.02
Manipal Academy of Higher Education (MAHE), India	0.333333	0.01

Interested in Bioinformatics and Computational Biology?